Managed Account Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$513K Sell
12,432
-173
-1% -$6.34K ﹤0.01% 2296
2015
Q1
$383K Sell
12,605
-1,727
-12% -$44.8K ﹤0.01% 2310
2014
Q4
$284K Sell
14,332
-300
-2% -$6.71K ﹤0.01% 2288
2014
Q3
$291K Buy
14,632
+296
+2% +$6.23K ﹤0.01% 2269
2014
Q2
$326K Sell
14,336
-2,213
-13% -$39.4K ﹤0.01% 2221
2014
Q1
$213K Sell
16,549
-23,377
-59% -$335K ﹤0.01% 2234
2013
Q4
$544K Buy
39,926
+1,702
+4% +$20.3K ﹤0.01% 2046
2013
Q3
$423K Buy
38,224
+20,712
+118% +$206K ﹤0.01% 2057
2013
Q2
$145K Buy
+17,512
New +$147K ﹤0.01% 2186

Other funds holding RGEN

Managed Account Advisors's RGEN Position: Q2 2015 in Review

Managed Account Advisors reduced its Repligen (RGEN) stake by 1.4% in Q2 2015, selling an estimated $6.34K and leaving 12,432 shares worth $513K. The position accounts for ﹤0.01% of the portfolio, ranked #2296.

Managed Account Advisors first reported a position in RGEN in Q2 2013 and has held it in 9 quarters since. The position peaked at $544K in Q4 2013. 174 funds tracked by Wall St. Rank hold RGEN as of Q2 2015.

  • Managed Account Advisors held 12,432 shares of Repligen worth $513K as of Q2 2015.
  • Managed Account Advisors sold 173 Repligen shares in Q2 2015, an estimated $6.34K.
  • Repligen made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2296 holding.
  • Managed Account Advisors first reported a position in Repligen in Q2 2013 and has held it in 9 quarters since.
  • Managed Account Advisors's Repligen position peaked at $544K in Q4 2013.
  • 174 funds tracked by Wall St. Rank held Repligen as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.